Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

Long-term inappropriate proton pump inhibitors use (PPIs) is a matter of concern because of the risks associated with their long-term use in older patients with chronic conditions. The risk of PPI treatment in hemodialysis patients remains unexplored. Methods: We assessed the relationship between th...

Full description

Bibliographic Details
Main Authors: Angel L.M. de Francisco, Javier Varas, Rosa Ramos, Jose Ignacio Merello, Bernard Canaud, Stefano Stuard, Julio Pascual, Pedro Aljama, P. Aljama, B. Canaud, A.L.M. De Francisco, A. Gauly, J. Luño, F. Maduell, A. Martin-Malo, J.I. Merello, J. Pascual, R. Pérez-Garcia, M. Praga, R. Ramos, S. Stuard, J. Varas, A. Zawada
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Kidney International Reports
Subjects:
hemodialysis
magnesium
mortality risk
proton pump inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917304369

Internet

http://www.sciencedirect.com/science/article/pii/S2468024917304369

Similar Items